SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-01-500103
Filing Date
2001-04-09
Accepted
2001-04-09 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 as01474003ac6.txt SC 13D/A 9357
  Complete submission text file 0000919574-01-500103.txt   11345
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48948 | Film No.: 1598133
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 730 FIFTH AVENUE 15TH FL NEW YORK NY 10019
Business Address 730 FIFTH AVENUE 15TH FLOOR NEW YORK NY 10019 2125741286
ANACONDA OPPORTUNITY FUND L P (Filed by) CIK: 0001021863 (see all company filings)

IRS No.: 521945748 | State of Incorp.: DE | Fiscal Year End: 0630